Online references only

References

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.

2. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94:9-14.

3. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. Br Med J. 1997;314:851-860.

4. Coccagna G, Mantovani M, Brignani F, Parchi C, Lugaresi E. Continuous recording of the pulmonary and systemic arterial pressure during sleep in syndromes of hypersomnia with periodic breathing. Bull Physio-path. 1972;8:1159-1172.

5. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Hemodynamics in sleep-induced apnea. Studies during wakefulness and sleep. Ann Intern Med. 1976;85:714-719.

6. Stokes J 3rd, Kannel WB, Wolf PA, D’Agostino RB, Cupples LA. Blood pressure as a risk factor for cardiovascular disease. The Framingham Study—30 years of follow-up. Hypertension. 1989;13:(5 suppl).

7. Hedner J, Grote L. Cardiovascular consequences of obstructive sleep apnea. In: McNicholas WT. Respiratory Disorders During Sleep (3). Sheffield, England: European Respiratory Society Journals Ltd; European Respiratory Monograph; 1998:227-265.

8. Koskenvuo M, Kaprio J, Partinen M, Langinvainio H, Sarna S, Heikkila K. Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985;1:893-896.

9. Lugaresi E, Cirignotta F, Coccagna G, Piana C. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep. 1980;3:221-224.

10. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746-1752.

11. Lavie P, Ben Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J. 1984;108:373-376.

12. Kales A, Bixler EO, Cadieux RJ, et al. Sleep apnoea in a hypertensive population. Lancet. 1984;2:1005-1008.

13. Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis. 1992;145:435-439.

14. Carlson JT, Hedner JA, Ejnell H, Peterson LE. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med. 1994;150:72-77.

15. Hoffstein V, Mateika J. Evening-to-morning blood pressure variations in snoring patients with and without obstructive sleep apnea. Chest. 1992;101:379-384.

16. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000;320:479-482.

17. Schneider H, Schaub CD, Andreoni KA, et al. Systemic and pulmonary hemodynamic responses to normal and obstructed breathing during sleep. J Appl Physiol. 1997;83:1671-1680.

18. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997;99:106-109.

19. Ehlenz K. Regulation of blood volume-implications for cardiovascular pathophysiology in sleep apnoea. J Sleep Res. 1995;4:30-33.

20. Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154:1490-1496.

21. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens. 1996;14:577-584.

22. Grote L, Kraiczi H, Hedner J. A modified vascular response in obstructive sleep apnea [abstract]. Deutsche Medizinische Wochenschrift. 1999;124:79.

23. Grote L, Ploch T, Heitmann J, Knaack L, Penzel T, Peter JH. Sleep related breathing disorders is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med. 1999;160:1875-1882.

24. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circ. 1998;96:308-315.

25. Kannel WB, Kannel C, Paffenbarger RSJ, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J. 1987;113:1489-1494.

26. Lindberg E, Janson C, Gislason T, Svaerdsudd K, Hetta J, Boman G. Snoring and hypertension: a 10-year follow up. Eur Respir J. 1998;11:884-889.

27. Hirshkowitz M, Karacan I, Gurakar C, Williams RL. Hypertension, erectile dysfunction, and occult sleep apnea. Sleep. 1989;12:223-232.

28. Isaksson H, Svanborg E. Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Nocturnal automatic blood pressure measurements—an aid to diagnosis? Clin Exp Hypertens A. 1991;13:A1195-A1212.

29. Grote L, Hedner J, Peter JH. Sleep related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertension. 2000;18:679-685.

30. Mayer J, Weichler U, Herres-Mayer B, Schneider H, Marx U, Peter JH. Influence of metoprolol and cilazapril on blood pressure and on sleep apnea activity. J Cardiovasc Pharmacol. 1990;16:952-961.

31. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide and losartan for antihypertensive treatment in obstructive sleep apnea. Am J Respir Crit Care Med. 2000;161:1423-1428.

32. Mayer J, Becker H, Brandenburg U, Penzel T, Peter JH, von Wichert P. Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology. 1991;79:84-92.

33. Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J. 1995;8:222-229.

34. Engleman HM, Gough K, Martin SE, Kingshott RN, Padfield PL, Douglas NJ. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers.” Sleep. 1996;19:378-381.

35. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension. 2000;35:144-147.